Indication and efficacy of PEIT in the management of secondary hyperparathyroidism
Open Access
- 24 July 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 1 (suppl 3), iii14-iii17
- https://doi.org/10.1093/ndtplus/sfn081
Abstract
Control of secondary hyperparathyroidism (SHPT) using active vitamin D analogues becomes difficult in advanced SHPT, because the enlarged parathyroid glands (PTGs) are resistant to medical therapy. Percutaneous ethanol injection therapy (PEIT) has been widely used in Japan since the 1990s as a surgical intervention for advanced SHPT, by selectively destroying only the enlarged glands with nodular hyperplasia (i.e. >0.5 cm3, measured by ultrasonography). If there is only one PTG with nodular hyperplasia, PEIT will be successful with a small number of injections, and it then becomes possible to maintain target levels of parathyroid hormone by treatment with active vitamin D analogues. Recent studies have demonstrated that in the advanced phase of SHPT, it is desirable to perform PEIT when it is restricted to patients with not more than one PTG larger than 0.5 cm3 in terms of superior prognosis can be obtained including efficacy, low recurrence, and long-term remission period.Keywords
This publication has 20 references indexed in Scilit:
- Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidismNephrology Dialysis Transplantation, 2006
- Treatment of Uremic Hyperparathyroidism with Percutaneous Ethanol InjectionNephron Clinical Practice, 2005
- Surgical Indications and Procedures of Parathyroidectomy in Patients with Chronic Kidney DiseaseTherapeutic Apheresis and Dialysis, 2005
- Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patientsNephrology Dialysis Transplantation, 2003
- Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color doppler flow mapping in chronic dialysis patientsAmerican Journal of Kidney Diseases, 1999
- Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidismKidney International, 1997
- Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patientsKidney International, 1994
- Serial Evaluation of Parathyroid Size by Ultrasonography Is Another Useful Marker for the Long-Term Prognosis of Calcitriol Pulse Therapy in Chronic Dialysis PatientsNephron, 1994
- Tertiary Hyperparathyroidism Treated by Ultrasonically Guided Percutaneous Fine-Needle Ethanol InjectionNephron, 1994
- Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.JCI Insight, 1993